ABBOTT is a wholesaler in Wavre. Public Limited, started on 6 September 1948, 1 establishment.

What is the address of ABBOTT?

The registered office of ABBOTT is located at Avenue Einstein 14, 1300 Wavre.

Is ABBOTT still active?

Yes. According to the CBE (29 October 2026) ABBOTT is active, legal situation “Normale toestand”, started on 6 September 1948.

Is ABBOTT registered on Peppol?

Yes, ABBOTT is registered on the Peppol network with ID 0208:0403044007.

What is the enterprise number of ABBOTT?

The enterprise number of ABBOTT is BE0403044007.

When was ABBOTT founded?

ABBOTT was founded on 6 September 1948.

Who are the directors of ABBOTT?

According to the 2025 annual accounts, the directors of ABBOTT are: Hasna Nadir, Maya Wakim, Slater Bradley Jay.

Is ABBOTT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 September 1948; 3 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did ABBOTT make in 2025?

ABBOTT posted a profit after taxes of € 369,805,439 in financial year 2025.

What is the revenue of ABBOTT?

In its most recent annual accounts (2025), ABBOTT reported revenue of € 105,622,923.

How much does an employee at ABBOTT earn?

The average wage cost per full-time employee at ABBOTT was € 192,700 in 2025: staff costs of € 13.7 million for 71.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ABBOTT have?

According to the 2025 annual accounts, ABBOTT has 71.2 full-time equivalents (FTE).

ABBOTT (Public Limited) - Wavre - BE0403044007

Dossier ABBOTT, printed on 29 October 2026 from databakkes.be/en/0403044007/abbott. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.
Shrinking team NBB

FTE fell two years in a row, from 775 to 71.2.
Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

ABBOTT from Wavre, company number BE0403044007, closed financial year 2025 with a result of € 369.8 million after tax. For that financial year ABBOTT recorded revenue of € 105.6 million and equity of € 2.1 billion. Compared with financial year 2024, the result moved from € -5.4 million to € 369.8 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 2.1 billion

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 369.8 million

▲ still € 5.4 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.1 million

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -540.4 million.

People and assets in 2025

Full-time equivalents

71.2

▼ 4.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 9.9 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 13.7 million

▲ 6% vs 2024

€ 192,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 282,957

▲ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13.1 million

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 55 days on average.

Taxes and wages

€ 5.2 million

▲ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Revenue	€ 93,634,042 Revenue 2023: € 93,634,042 First fiscal year in the series	€ 98,335,821 Revenue 2024: € 98,335,821 ▲ 5% vs 2023 (€ 93,634,042) Favourable step	€ 105,622,923 Revenue 2025: € 105,622,923 ▲ 7% vs 2024 (€ 98,335,821) Favourable step	▲ 7%
Profit after taxes	€ -4,282,932 Profit after taxes 2023: € -4,282,932 First fiscal year in the series	€ -5,417,863 Profit after taxes 2024: € -5,417,863 ▼ € 1.1 million vs 2023 (€ -4,282,932) Unfavourable step	€ 369,805,439 Profit after taxes 2025: € 369,805,439 ▲ € 375.2 million vs 2024 (€ -5,417,863) Favourable step	▲ € 375.2 million
Equity	€ 2,109,872,473 Equity 2023: € 2,109,872,473 First fiscal year in the series	€ 2,104,454,610 Equity 2024: € 2,104,454,610 Unchanged (€ 2,109,872,473) Unfavourable step	€ 2,104,805,504 Equity 2025: € 2,104,805,504 Unchanged (€ 2,104,454,610) Favourable step
Total debts	€ 225,153,881 Total debts 2023: € 225,153,881 First fiscal year in the series	€ 233,678,399 Total debts 2024: € 233,678,399 ▲ 4% vs 2023 (€ 225,153,881) Unfavourable step	€ 232,106,795 Total debts 2025: € 232,106,795 ▼ 1% vs 2024 (€ 233,678,399) Favourable step	▼ 1%
Cash	€ 4,486,984 Cash 2023: € 4,486,984 First fiscal year in the series	€ 2,596,730 Cash 2024: € 2,596,730 ▼ 42% vs 2023 (€ 4,486,984) Unfavourable step	€ 1,076,318 Cash 2025: € 1,076,318 ▼ 59% vs 2024 (€ 2,596,730) Unfavourable step	▼ 59%
Retained profit	€ -904,751,584 Retained profit 2023: € -904,751,584 First fiscal year in the series	€ -910,169,447 Retained profit 2024: € -910,169,447 ▼ € 5.4 million vs 2023 (€ -904,751,584) Unfavourable step	€ -540,364,008 Retained profit 2025: € -540,364,008 ▲ € 369.8 million vs 2024 (€ -910,169,447) Favourable step	▲ € 369.8 million
Balance sheet total	€ 2,335,788,104 Balance sheet total 2023: € 2,335,788,104 First fiscal year in the series	€ 2,339,137,298 Balance sheet total 2024: € 2,339,137,298 Unchanged (€ 2,335,788,104) Unchanged	€ 2,338,136,381 Balance sheet total 2025: € 2,338,136,381 Unchanged (€ 2,339,137,298) Unchanged
Employees (FTE)	775 Employees (FTE) 2023: 775 First fiscal year in the series	75.8 Employees (FTE) 2024: 75.8 ▼ 699.2 vs 2023 (775) Unchanged	71.2 Employees (FTE) 2025: 71.2 ▼ 4.6 vs 2024 (75.8) Unchanged	▼ 4.6

Key figures of ABBOTT, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ABBOTT?

What happened at ABBOTT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Maya Wakim stepped down as director. NBB
2028 Slater Bradley Jay stepped down as director. NBB
2027 Hasna Nadir stepped down as director. NBB
Jul 3, 2026 New annual accounts for financial year 2025: profit of € 369.8 million. Source: NBB ↗
2026 Maya Wakim became a director. NBB
2022 Slater Bradley Jay became a director. NBB
2022 Hasna Nadir became a director. NBB
Mar 15, 1977 New establishment in Wavre. KBO

In short

From € 4.3 million loss in 2023 to € 369.8 million profit in 2025.

Paid € 137,733 in corporate taxes since 2023.

Best year ever: 2025, with € 369.8 million profit.

Pays suppliers within 55 days on average.

Original PDFs at the National Bank ↗

Management

St Jude Medical International Holding 100%

Abbott Holding Gibraltar Limited 0%

ABBOTT

Abbott Medical Italia SPA 100%

Abbott Medical Belgium BV 100%

ABBOTT srl 100%

KNOLL UK INVESTMENTS UNLIMITED 100%

The shares are held by St Jude Medical International Holding (100%) and Abbott Holding Gibraltar Limited (0%). It owns 100% of Abbott Medical Italia SPA, 100% of Abbott Medical Belgium BV, 100% of ABBOTT srl, 100% of KNOLL UK INVESTMENTS UNLIMITED, 100% of Abbott Norge AS and 100% of Abbott Medical Hellas itself.

Directors

According to the 2025 annual accounts

Hasna Nadir

Director

since 2022 · until 2027

Maya Wakim

Director

since 2026 · until 2031

Slater Bradley Jay

Director

since 2022 · until 2028

Shareholders

St Jude Medical International Holding

100%

Abbott Holding Gibraltar Limited

Participations

Abbott Medical Italia SPA

100%

Abbott Medical Belgium BV

100%

ABBOTT srl

100%

KNOLL UK INVESTMENTS UNLIMITED

100%

Abbott Norge AS

100%

Abbott Medical Hellas

100%

ABBOTT LABORATORIOS LDA

100%

Abbott Rapid Diagnostics BV

100%

ABBOTT ASIA INVESTMENTS LTD

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Einstein 14

1300 Wavre

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

SYNDESI THERAPEUTICS

€ -6.5 million gross margin · 2025

ABBVIE

€ 265.6 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0403.044.007

VAT number

BE 0403.044.007

Registered office

Avenue Einstein 14, 1300 Wavre

Names & denominations

ABBOTT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

6 September 1948

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

ABBOTT

Warning lights

Financials

What happened to ABBOTT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions